Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2022	Sep. 30, 2021
Current assets:
Cash and cash equivalents	$ 206	$ 168
Accounts and notes receivable, net of reserve for doubtful accounts of $3 and $4	836	645
Inventories	664	523
Prepaid expenses and other current assets	114	89
Total current assets	1,820	1,425
Property, plant and equipment	3,554	3,885
Accumulated depreciation	(2,284)	(2,509)
Net property, plant and equipment	1,270	1,376
Goodwill	129	140	[1]
Equity affiliates	20	40
Intangible assets, net	63	100
Deferred income taxes	45	53
Other assets	178	172
Total assets	3,525	3,306
Current liabilities:
Short-term borrowings	347	72
Accounts payable and accrued liabilities	707	667
Income taxes payable	44	35
Current portion of long-term debt	7	373
Total current liabilities	1,105	1,147
Long-term debt	1,089	717
Deferred income taxes	65	73
Other liabilities	234	279
Commitments and contingencies (Note S)
Preferred stock:
Authorized: 2,000,000 shares of $1 par value, Issued and Outstanding: None and none
Common stock:
Authorized: 200,000,000 shares of $1 par value, Issued: 56,385,963 and 56,870,237 shares, Outstanding: 56,248,559 and 56,726,818 shares	56	57
Less cost of 137,404 and 143,419 shares of common treasury stock	(4)	(4)
Additional paid-in capital	1	24
Retained earnings	1,284	1,159
Accumulated other comprehensive income (loss)	(439)	(289)
Total Cabot Corporation stockholders’ equity	898	947
Noncontrolling interests	134	143
Total stockholders’ equity	1,032	1,090
Total liabilities and stockholders’ equity	$ 3,525	$ 3,306

[1] The balance as of September 30, 2021 included $444 million of accumulated impairment losses associated with the goodwill of Purification Solutions segment. There were no accumulated impairment losses associated with the goodwill of the Reinforcement Materials or Performance Chemicals segments.